1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Radiopharmaceutical Preclinical CRO Market
2.2. Global Radiopharmaceutical Preclinical CRO Market, By Service Type, 2023 (US$ Million)
2.3. Global Radiopharmaceutical Preclinical CRO Market, By End-Use Industry, 2023 (US$ Million)
2.4. Global Radiopharmaceutical Preclinical CRO Market, By Radiopharmaceutical Type, 2023 (US$ Million)
2.5. Global Radiopharmaceutical Preclinical CRO Market, By Therapeutic Area, 2023 (US$ Million)
2.6. Global Radiopharmaceutical Preclinical CRO Market, By Organization Size, 2023 (US$ Million)
2.7. Global Radiopharmaceutical Preclinical CRO Market, By Geography, 2023 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2023

3. Radiopharmaceutical Preclinical CRO Market: Competitive Analysis
3.1. Market Positioning of Key Radiopharmaceutical Preclinical CRO Market Vendors
3.2. Strategies Adopted by Radiopharmaceutical Preclinical CRO Market Vendors
3.3. Key Industry Strategies
4. Radiopharmaceutical Preclinical CRO Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Radiopharmaceutical Preclinical CRO Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Safety Assessment
5.3.2. Bioanalytical Testing
5.3.3. Dose Formulation
5.3.4. Regulatory Affairs Support

6. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Pharmaceutical Companies
6.3.2. Biotechnology Firms
6.3.3. Academic Research Institutions
6.3.4. Government Organizations

7. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. PET Tracers
7.3.2. SPECT Tracers
7.3.3. Therapeutic Radiopharmaceuticals

8. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Market Segmentation
8.3.1. Oncology
8.3.2. Cardiology
8.3.3. Neurology
8.3.4. Others

9. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2023 Versus 2032
9.3. Market Segmentation
9.3.1. Small and Medium Enterprises (SMEs)
9.3.2. Large Pharmaceutical Corporations


10. North America Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
10.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
10.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
10.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
10.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
10.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
10.7.1.North America
10.7.1.1. U.S.
10.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
10.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
10.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
10.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
10.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
10.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
10.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
10.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
10.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
10.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
10.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
10.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
10.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

11. UK and European Union Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
11.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
11.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
11.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
11.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
11.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
11.7.1.UK and European Union
11.7.1.1. UK
11.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
11.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
11.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
11.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
11.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
11.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
11.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
11.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
11.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
11.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
11.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
11.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
11.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
11.7.1.4.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
11.7.1.4.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
11.7.1.4.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
11.7.1.4.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
11.7.1.5. France
11.7.1.5.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
11.7.1.5.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
11.7.1.5.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
11.7.1.5.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
11.7.1.5.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
11.7.1.6.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
11.7.1.6.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
11.7.1.6.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
11.7.1.6.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

12. Asia Pacific Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
12.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
12.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
12.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
12.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
12.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
12.7.1.Asia Pacific
12.7.1.1. China
12.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
12.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
12.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
12.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
12.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
12.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
12.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
12.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
12.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
12.7.1.3. India
12.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
12.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
12.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
12.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
12.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
12.7.1.4.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
12.7.1.4.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
12.7.1.4.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
12.7.1.4.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
12.7.1.5.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
12.7.1.5.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
12.7.1.5.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
12.7.1.5.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
12.7.1.6. Rest of Asia Pacific
12.7.1.6.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
12.7.1.6.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
12.7.1.6.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
12.7.1.6.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
12.7.1.6.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

13. Latin America Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)
13.1. Market Overview
13.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
13.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
13.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
13.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
13.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
13.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
13.7.1.Latin America
13.7.1.1. Brazil
13.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
13.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
13.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
13.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
13.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
13.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
13.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
13.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
13.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
13.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
13.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
13.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
13.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

14. Middle East and Africa Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)
14.1. Market Overview
14.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
14.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
14.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
14.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
14.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
14.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
14.7.1.Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
14.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
14.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
14.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
14.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
14.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
14.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
14.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
14.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
14.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
14.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
14.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
14.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

15. Company Profile
15.1. Charles River Laboratories International, Inc.
15.1.1. Company Overview
15.1.2. Financial Performance
15.1.3. Product Portfolio
15.1.4. Strategic Initiatives
15.2. Pharmaron Beijing Co., Ltd.
15.2.1. Company Overview
15.2.2. Financial Performance
15.2.3. Product Portfolio
15.2.4. Strategic Initiatives
15.3. Bioscan, Inc.
15.3.1. Company Overview
15.3.2. Financial Performance
15.3.3. Product Portfolio
15.3.4. Strategic Initiatives
15.4. Invicro (Konica Minolta)
15.4.1. Company Overview
15.4.2. Financial Performance
15.4.3. Product Portfolio
15.4.4. Strategic Initiatives
15.5. PerkinElmer, Inc.
15.5.1. Company Overview
15.5.2. Financial Performance
15.5.3. Product Portfolio
15.5.4. Strategic Initiatives
15.6. Siemens Healthineers
15.6.1. Company Overview
15.6.2. Financial Performance
15.6.3. Product Portfolio
15.6.4. Strategic Initiatives
15.7. IBA Radiopharma Solutions
15.7.1. Company Overview
15.7.2. Financial Performance
15.7.3. Product Portfolio
15.7.4. Strategic Initiatives
15.8. Covance, Inc. (Labcorp Drug Development)
15.8.1. Company Overview
15.8.2. Financial Performance
15.8.3. Product Portfolio
15.8.4. Strategic Initiatives
15.9. NorthStar Medical Radioisotopes, LLC
15.9.1. Company Overview
15.9.2. Financial Performance
15.9.3. Product Portfolio
15.9.4. Strategic Initiatives
15.10. PAREXEL International Corporation
15.10.1. Company Overview
15.10.2. Financial Performance
15.10.3. Product Portfolio
15.10.4. Strategic Initiatives
15.11. Eckert & Ziegler
15.11.1. Company Overview
15.11.2. Financial Performance
15.11.3. Product Portfolio
15.11.4. Strategic Initiatives
15.12. Jubilant Radiopharma
15.12.1. Company Overview
15.12.2. Financial Performance
15.12.3. Product Portfolio
15.12.4. Strategic Initiatives
15.13. Cardinal Health, Inc.
15.13.1. Company Overview
15.13.2. Financial Performance
15.13.3. Product Portfolio
15.13.4. Strategic Initiatives
15.14. Curium Pharma
15.14.1. Company Overview
15.14.2. Financial Performance
15.14.3. Product Portfolio
15.14.4. Strategic Initiatives
15.15. ImaginAb, Inc.
15.15.1. Company Overview
15.15.2. Financial Performance
15.15.3. Product Portfolio
15.15.4. Strategic Initiatives
15.16. Other Notable Players
15.16.1. Company Overview
15.16.2. Financial Performance
15.16.3. Product Portfolio
15.16.4. Strategic Initiatives